The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis

Ewa M Roos, L Stefan Lohmander, Ewa M Roos, L Stefan Lohmander

Abstract

The Knee injury and Osteoarthritis Outcome Score (KOOS) was developed as an extension of the WOMAC Osteoarthritis Index with the purpose of evaluating short-term and long-term symptoms and function in subjects with knee injury and osteoarthritis. The KOOS holds five separately scored subscales: Pain, other Symptoms, Function in daily living (ADL), Function in Sport and Recreation (Sport/Rec), and knee-related Quality of Life (QOL). The KOOS has been validated for several orthopaedic interventions such as anterior cruciate ligament reconstruction, meniscectomy and total knee replacement. In addition the instrument has been used to evaluate physical therapy, nutritional supplementation and glucosamine supplementation. The effect size is generally largest for the subscale QOL followed by the subscale Pain. The KOOS is a valid, reliable and responsive self-administered instrument that can be used for short-term and long-term follow-up of several types of knee injury including osteoarthritis. The measure is relatively new and further use of the instrument will add knowledge and suggest areas that need to be further explored and improved.

Figures

Figure 1
Figure 1
Development and evaluation of the KOOS.
Figure 2
Figure 2
Effect sizes of KOOS, WOMAC and SF-36 six months after ACL-reconstruction. Comparison of effect sizes of KOOS, WOMAC and SF-36 six months after surgical reconstruction of the ruptured anterior cruciate ligament. Effect size was defined as mean score change divided by the pre-operative standard deviation. The data are previously published (n = 21, mean age 32 years) [5]. Placebo or sham treatment results have not been subtracted to generate effect sizes. It should be noted that the effect size displayed here will be influenced by the preoperative within-group variation of the score dimension measured.
Figure 3
Figure 3
Effect size for different surgical interventions measured by KOOS. KOOS effect sizes 6 months following surgical knee interventions. Effect size was defined as mean score change divided by the pre-operative standard deviation. The data from total knee replacement [8] (n = 105, mean age 71.3 years) and anterior cruciate ligament reconstruction [5] (n = 21, mean age 32 years) are previously published. The data from tibial osteotomy concerns 50 patients (mean age 54 years) undergoing hemicallotasis osteotomy (W-Dahl A, Lund University, personal communication 2001). The data from cartilage repair concerns 50 patients (mean age 34 years) undergoing autologus cartilage transplant (Olsson M, University of Gothenburg, personal communication 2002). The data for meniscectomy concern 66 patients (mean age 44 years) undergoing arthroscopic partial meniscectomy (Roos E, Lund University, personal communication 2003). Placebo or sham treatment results have not been subtracted to generate effect sizes. It should be noted that the effect size displayed here will be influenced by the preoperative within-group variation of the score dimension measured. This may vary between the different study groups. All data are published with permission from the authors.

References

    1. Tegner Y, Lysholm J. Rating systems in the evaluation of knee ligament injuries. Clin Orthop. 1985:43–49.
    1. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833–1840.
    1. Flandry F, Hunt JP, Terry GC, Hughston JC. Analysis of subjective knee complaints using visual analog scales. Am J Sports Med. 1991;19:112–118.
    1. Mohtadi N. Development and validation of the quality of life outcome measure (questionnaire) for chronic anterior cruciate ligament deficiency. Am J Sports Med. 1998;26:350–359.
    1. Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee Injury and Osteoarthritis Outcome Score (KOOS)--development of a self-administered outcome measure. J Orthop Sports Phys Ther. 1998;28:88–96.
    1. Roos EM, Roos HP, Ekdahl C, Lohmander LS. Knee injury and Osteoarthritis Outcome Score (KOOS)--validation of a Swedish version. Scand J Med Sci Sports. 1998;8:439–448.
    1. Roos EM, Roos HP, Lohmander LS. WOMAC Osteoarthritis Index--additional dimensions for use in subjects with post-traumatic osteoarthritis of the knee. Western Ontario and MacMaster Universities. Osteoarthritis Cartilage. 1999;7:216–221. doi: 10.1053/joca.1998.0153.
    1. Roos EM, Toksvig-Larsen S. Knee injury and Osteoarthritis Outcome Score (KOOS) - validation and comparison to the WOMAC in total knee replacement. Health Qual Life Outcomes. 2003;1:17. doi: 10.1186/1477-7525-1-17.
    1. Ware J. E., Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483.
    1. Kessler S, Lang S, Puhl W, Stove J. [The knee injury and osteoarthritis outcome score - a multifunctional questionnaire to measure outcome in knee arthroplasty] Z Orthop Ihre Grenzgeb. 2003;141:277–282. doi: 10.1055/s-2003-38658.
    1. Roos EM, Brandsson S, Karlsson J. Validation of the foot and ankle outcome score for ankle ligament reconstruction. Foot Ankle Int. 2001;22:788–794.
    1. Nilsdotter AK, Lohmander SL, Klassbo M, Roos EM. Hip Disability and Osteoarthritis Outcome Score (HOOS) - Validity and responsiveness in total hip replacement. BMC Musculoskelet Disord. 2003;4:10. doi: 10.1186/1471-2474-4-10.
    1. Bremander AB, Petersson IF, Roos EM. Validation of the Rheumatoid and Arthritis Outcome Score (RAOS) for the lower extremity. Health Qual Life Outcomes. 2003;1:55. doi: 10.1186/1477-7525-1-55.
    1. Nau T, Lavoie P, Duval N. A new generation of artificial ligaments in reconstruction of the anterior cruciate ligament. Two-year follow-up of a randomised trial. J Bone Joint Surg Br. 2002;84:356–360. doi: 10.1302/0301-620X.84B3.12400.
    1. Braham R, Dawson B, Goodman C. The effect of glucosamine supplementation on people experiencing regular knee pain. Br J Sports Med. 2003;37:45–49. doi: 10.1136/bjsm.37.1.45.
    1. Colker CM, Swain M, Lynch L, Gingerich DA. Effects of a milk-based bioactive micronutrient beverage on pain symptoms and activity of adults with osteoarthritis: a double-blind, placebo-controlled clinical evaluation. Nutrition. 2002;18:388–392. doi: 10.1016/S0899-9007(01)00800-0.
    1. Ask S, Lindmark B, Johansson A. [Evaluation of the use of continuous passive motion (CPM) in rehabilitation following total knee replacement] Nordisk Fysioterapi. 2003;7:29–39.
    1. Ehrich EW, Davies GM, Watson DJ, Bolognese JA, Seidenberg BC, Bellamy N. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis. J Rheumatol. 2000;27:2635–2641.
    1. Ostenberg A, Roos E, Ekdahl C, Roos H. Physical capacity in female soccer players -does age make a difference? Advances in Physiotherapy. 2000;2:39–48. doi: 10.1080/140381900443427.
    1. Roos H, Lauren M, Adalberth T, Roos EM, Jonsson K, Lohmander LS. Knee osteoarthritis after meniscectomy: prevalence of radiographic changes after twenty-one years, compared with matched controls. Arthritis Rheum. 1998;41:687–693. doi: 10.1002/1529-0131(199804)41:4<687::AID-ART16>;2-2.
    1. Lohmander LS, Roos H. Knee ligament injury, surgery and osteoarthrosis. Truth or consequences? Acta Orthop Scand. 1994;65:605–609.
    1. Englund M, Roos EM, Lohmander LS. Impact of type of meniscal tear on radiographic and symptomatic knee osteoarthritis: a sixteen-year followup of meniscectomy with matched controls. Arthritis Rheum. 2003;48:2178–2187. doi: 10.1002/art.11088.
    1. von Porat A, Roos EM, Roos H. High prevalence of osteoarthritis 14 years after an anterior cruciate ligament tear in male soccer players - A study of radiographic and patient-relevant outcomes. Ann Rheum Dis. 2003;In press

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit